279 filings
Page 6 of 14
8-K
43mlcyuc62 mm
30 Oct 19
Epizyme Announces PositivePre-NDA Meeting for Tazemetostat for Follicular
6:38am
8-K
raqaqig1t a2r
4 Sep 19
Epizyme Announces Board of Director Appointments to Support Continued Evolution and Growth
4:16pm
8-K
7zjwl
19 Aug 19
Entry into a Material Definitive Agreement
4:42pm
8-K
kbkvjdj1rfg0
9 Aug 19
Epizyme Reports Business Progress and Second Quarter 2019 Results
6:34am
8-K
o84jnf czru
22 Jul 19
Epizyme Strengthens Leadership Team with Appointment of Paolo Tombesi as Chief Financial Officer
4:01pm
8-K
a7um115u cslijxv
3 Jun 19
Submission of Matters to a Vote of Security Holders
4:13pm
CT ORDER
fdt h483rhfzg
22 May 19
Confidential treatment order
4:04pm
8-K
r2wdc zxit
6 May 19
Epizyme Provides Business Update and Reports First Quarter 2019 Financial Results
6:39am
DEFA14A
91h932t chst
18 Apr 19
Additional proxy soliciting materials
6:17am
CT ORDER
et94pmj fwb0
19 Mar 19
Confidential treatment order
12:00am
424B5
37j 8evmfhwhs1v
7 Mar 19
Prospectus supplement for primary offering
4:22pm
424B5
v6aot8
7 Mar 19
Prospectus supplement for primary offering
4:19pm
8-K
rbrftld ujx3eai6
7 Mar 19
Amendments to Articles of Incorporation or Bylaws
4:12pm
424B5
2eq5yle
6 Mar 19
Prospectus supplement for primary offering
5:28pm
424B5
6b71 qpqd
6 Mar 19
Prospectus supplement for primary offering
5:28pm
8-K
42hv677269a582ow1z8
1 Mar 19
Other Events
12:00am